Bering Capital
North America, California, United States, San Francisco
Description
Venture capital firm investing in biopharmaceuticals and medical devices.
Investor Profile
Bering Capital has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Post Ipo Equity, Series D rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Information Technology, Life Science.
Stage Focus
- Series C (50%)
- Post Ipo Equity (25%)
- Series D (25%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Information Technology
- Life Science
- Biopharma
- Biotechnology
- Oncology
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
